Published in Transgenic Res on August 20, 2014
FGF signaling in the osteoprogenitor lineage non-autonomously regulates postnatal chondrocyte proliferation and skeletal growth. Development (2016) 0.80
Mediator MED23 cooperates with RUNX2 to drive osteoblast differentiation and bone development. Nat Commun (2016) 0.79
Low bone mass and changes in the osteocyte network in mice lacking autophagy in the osteoblast lineage. Sci Rep (2016) 0.78
Smad4 controls bone homeostasis through regulation of osteoblast/osteocyte viability. Exp Mol Med (2016) 0.77
Multiple essential MT1-MMP functions in tooth root formation, dentinogenesis, and tooth eruption. Matrix Biol (2016) 0.77
Loss of Iroquois homeobox transcription factors 3 and 5 in osteoblasts disrupts cranial mineralization. Bone Rep (2016) 0.75
Tgfbr2 is required in osterix expressing cells for postnatal skeletal development. Bone (2016) 0.75
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell (1997) 18.91
The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell (2002) 15.20
Germ-line transformation of mice. Annu Rev Genet (1986) 8.67
Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development (2006) 7.08
Erythroid-specific expression of human beta-globin genes in transgenic mice. EMBO J (1985) 5.84
The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J Clin Invest (2010) 1.98
BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development (2008) 1.86
Engineering chromosomal rearrangements in mice. Nat Rev Genet (2001) 1.85
Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab (2010) 1.79
Cre/loxP recombination system and gene targeting. Methods Mol Biol (2002) 1.64
Insertional mutation of 'classical' and novel genes in transgenic mice. Trends Genet (1992) 1.45
Osx-Cre targets multiple cell types besides osteoblast lineage in postnatal mice. PLoS One (2014) 1.38
A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5' end of Pkd1. Kidney Int (2008) 1.30
Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat. PLoS One (2010) 1.29
Decreased body weight in young Osterix-Cre transgenic mice results in delayed cortical bone expansion and accrual. Transgenic Res (2011) 1.24
Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development. J Biol Chem (2011) 1.02
In vivo expression of Osterix in mature granule cells of adult mouse olfactory bulb. Biochem Biophys Res Commun (2011) 0.86
G alpha(q) signal in osteoblasts is inhibitory to the osteoanabolic action of parathyroid hormone. J Biol Chem (2011) 0.81
Genetic and pathologic aspects of retinoic acid-induced limb malformations in the mouse. Birth Defects Res A Clin Mol Teratol (2010) 0.81
Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med (2010) 4.88
Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med (2008) 3.98
Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol (2008) 2.85
Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol Biol Cell (2008) 2.78
Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation. J Clin Invest (2012) 2.58
Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development (2002) 2.57
Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc Natl Acad Sci U S A (2002) 2.54
VEGFA is necessary for chondrocyte survival during bone development. Development (2004) 2.54
Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol (2005) 2.38
NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J Clin Invest (2008) 2.29
Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice. Cell (2007) 2.18
Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J (2002) 2.13
Identification of signaling pathways regulating primary cilium length and flow-mediated adaptation. Curr Biol (2010) 2.08
Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis. Arthritis Rheum (2007) 2.07
Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res (2005) 1.92
The genetic basis for skeletal diseases. Nature (2003) 1.92
Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair. Curr Top Dev Biol (2005) 1.75
Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas"). Am J Hum Genet (2002) 1.66
Knobloch syndrome: novel mutations in COL18A1, evidence for genetic heterogeneity, and a functionally impaired polymorphism in endostatin. Hum Mutat (2004) 1.61
Editorial: Journal of negative results in biomedicine. J Negat Results Biomed (2002) 1.58
Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development. Development (2004) 1.58
Localization of collagen XVIII and the endostatin portion of collagen XVIII in aged human control eyes and eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci (2004) 1.56
Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice. J Biol Chem (2004) 1.53
FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis. J Cell Biol (2008) 1.53
Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. EMBO J (2003) 1.53
The role of backscattering in SHG tissue imaging. Biophys J (2007) 1.43
Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression. Cancer Res (2004) 1.42
Cherubism: best clinical practice. Orphanet J Rare Dis (2012) 1.42
Physiological role of collagen XVIII and endostatin. FASEB J (2005) 1.40
Differential expression of CD146 in tissues and endothelial cells derived from infantile haemangioma and normal human skin. J Pathol (2003) 1.35
Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J Invest Dermatol (2004) 1.34
Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function. EMBO J (2003) 1.34
Loss of collagen XVIII enhances neovascularization and vascular permeability in atherosclerosis. Circulation (2004) 1.30
Molecular interplay between endostatin, integrins, and heparan sulfate. J Biol Chem (2009) 1.25
Progression of calvarial bone development requires Foxc1 regulation of Msx2 and Alx4. Dev Biol (2003) 1.23
Targeted disruption of Col8a1 and Col8a2 genes in mice leads to anterior segment abnormalities in the eye. FASEB J (2005) 1.18
Kinesin-2 controls development and patterning of the vertebrate skeleton by Hedgehog- and Gli3-dependent mechanisms. Dev Biol (2007) 1.15
Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling: role of divalent cations. J Biol Chem (2003) 1.07
Growth of cranial synchondroses and sutures requires polycystin-1. Dev Biol (2008) 1.06
Commitment to the osteoblast lineage is not required for RANKL gene expression. J Biol Chem (2009) 1.05
Infantile hemangioma: challenges, new insights, and therapeutic promise. J Craniofac Surg (2009) 1.04
Endogenous endostatin inhibits choroidal neovascularization. FASEB J (2007) 1.03
Two-dimensional nanoscale structural and functional imaging in individual collagen type I fibrils. Biophys J (2010) 1.02
Rapamycin inhibits proliferation of hemangioma endothelial cells by reducing HIF-1-dependent expression of VEGF. PLoS One (2012) 1.01
Second harmonic generation imaging of fascia within thick tissue block. Opt Express (2007) 1.01
Multimodal nonlinear optical imaging of collagen arrays. J Struct Biol (2008) 1.00
Signaling mechanisms in infantile hemangioma. Curr Opin Hematol (2009) 1.00
Risk of vascular anomalies with Down syndrome. Pediatrics (2008) 1.00
Mechanical force-induced midpalatal suture remodeling in mice. Bone (2007) 1.00
Wnt/beta-catenin--a canonical tale of cell-fate choice in the vertebrate skeleton. Dev Cell (2005) 0.99
A novel missense mutation in the paired domain of PAX9 causes non-syndromic oligodontia. Hum Genet (2003) 0.98
The first draft of the endostatin interaction network. J Biol Chem (2009) 0.98
The role of structural genes in the pathogenesis of osteoarthritic disorders. Arthritis Res (2002) 0.97
The polycystic kidney disease 1 (Pkd1) gene is required for the responses of osteochondroprogenitor cells to midpalatal suture expansion in mice. Bone (2009) 0.96
Age-dependent iris abnormalities in collagen XVIII/endostatin deficient mice with similarities to human pigment dispersion syndrome. Invest Ophthalmol Vis Sci (2003) 0.96
The role of endothelial-mesenchymal transition in heterotopic ossification. J Bone Miner Res (2012) 0.95
The role of SH3BP2 in the pathophysiology of cherubism. Orphanet J Rare Dis (2012) 0.95
Groucho homologue Grg5 interacts with the transcription factor Runx2-Cbfa1 and modulates its activity during postnatal growth in mice. Dev Biol (2004) 0.94
Transglutaminase-2: a new endostatin partner in the extracellular matrix of endothelial cells. Biochem J (2010) 0.94
Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair. J Clin Invest (2016) 0.94
Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice. Am J Pathol (2004) 0.92
Col2-Cre recombinase is co-expressed with endogenous type II collagen in embryonic renal epithelium and drives development of polycystic kidney disease following inactivation of ciliary genes. Matrix Biol (2008) 0.91
Impaired skin and hair follicle development in Runx2 deficient mice. Dev Biol (2008) 0.89
How vascular endothelial growth factor-A (VEGF) regulates differentiation of mesenchymal stem cells. J Histochem Cytochem (2013) 0.88
Matrix remodeling as stem cell recruitment event: a novel in vitro model for homing of human bone marrow stromal cells to the site of injury shows crucial role of extracellular collagen matrix. Matrix Biol (2010) 0.88
Genetics and experimental models of crystal-induced arthritis. Lessons learned from mice and men: is it crystal clear? Curr Opin Rheumatol (2007) 0.88
FoxA family members are crucial regulators of the hypertrophic chondrocyte differentiation program. Dev Cell (2012) 0.88
Osteoblast-adipocyte lineage plasticity in tissue development, maintenance and pathology. Cell Mol Life Sci (2013) 0.88
Imaging skeletal muscle using second harmonic generation and coherent anti-Stokes Raman scattering microscopy. Biomed Opt Express (2011) 0.86
Growth defect in Grg5 null mice is associated with reduced Ihh signaling in growth plates. Dev Dyn (2002) 0.86
Non-viral endostatin plasmid transfection of mesenchymal stem cells via collagen scaffolds. Biomaterials (2008) 0.86
Treatment with the angiogenesis inhibitor endostatin: a novel therapy in rheumatoid arthritis. J Rheumatol (2002) 0.85
Mouse AMACO, a kidney and skin basement membrane associated molecule that mediates RGD-dependent cell attachment. Matrix Biol (2009) 0.85
An evolutionarily conserved enhancer regulates Bmp4 expression in developing incisor and limb bud. PLoS One (2012) 0.84
Opening peer-review: the democracy of science. J Negat Results Biomed (2014) 0.84
Cherubism gene Sh3bp2 is important for optimal bone formation, osteoblast differentiation, and function. Am J Orthod Dentofacial Orthop (2010) 0.83
Why cellular stress suppresses adipogenesis in skeletal tissue, but is ineffective in adipose tissue: control of mesenchymal cell differentiation via integrin binding sites in extracellular matrices. Matrix Biol (2013) 0.82
A new Adamts9 conditional mouse allele identifies its non-redundant role in interdigital web regression. Genesis (2014) 0.82
Retracted Recent progress in studies of infantile hemangioma. J Dermatol (2010) 0.82
Unexpected matrix diseases and novel therapeutic strategies. Cell Tissue Res (2009) 0.82
Engineering endostatin-producing cartilaginous constructs for cartilage repair using nonviral transfection of chondrocyte-seeded and mesenchymal-stem-cell-seeded collagen scaffolds. Tissue Eng Part A (2010) 0.81
Recent progress in studies of infantile hemangioma. J Dermatol (2010) 0.81
Endostatin's heparan sulfate-binding site is essential for inhibition of angiogenesis and enhances in situ binding to capillary-like structures in bone explants. Matrix Biol (2004) 0.81
On bone-forming cells and blood vessels in bone development. Cell Metab (2010) 0.81
Lack of type VIII collagen in mice ameliorates diabetic nephropathy. Diabetes (2009) 0.80
Type XVIII collagen is essential for survival during acute liver injury in mice. Dis Model Mech (2013) 0.79
Distinct VEGF functions during bone development and homeostasis. Arch Immunol Ther Exp (Warsz) (2014) 0.79
Transforming blood vessels into bone. Cell Cycle (2011) 0.78
Tankyrase loses its grip on SH3BP2 in cherubism. Cell (2011) 0.78
Engineering endostatin-expressing cartilaginous constructs using injectable biopolymer hydrogels. Acta Biomater (2012) 0.77
Presphenoidal synchondrosis fusion in DBA/2J mice. Mamm Genome (2012) 0.77
Role of polycystin-1 in bone remodeling: orthodontic tooth movement study in mutant mice. Angle Orthod (2014) 0.75
From the Editor's Desk. Matrix Biol (2005) 0.75
Anthrax toxin receptors and infantile systemic hyalinosis. Matrix Biol (2007) 0.75